SCHEMBL6504869

SCHEMBL6504869

CCOC(=O)c1c(N)c(C(N)=O)nn1-c1cccc(Cl)c1F

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.54
KDM4E B2RXH2 4/20 0.54
HPGD P15428 1/20 0.54
HSD17B10 Q99714 1/20 0.54
PDE4B Q07343 5/20 0.45
RIPK1 Q13546 1/20 0.43
NPSR1 Q6W5P4 2/20 0.43
MAPT P10636 2/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PDE4A P27815 4/20 0.40
PDE4C Q08493 4/20 0.40
PDE4D Q08499 4/20 0.40
GAA P10253 1/20 0.40
ALOX15 P16050 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ADORA1 P30542 1/20 0.39
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6469895 0.83 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDHSD17B10NPSR1
SCHEMBL6498887 0.82 RIPK1 (0.45) ALDH1A1KDM4EHPGDHSD17B10RIPK1
Potassium SCHEMBL6498895 0.82 RIPK1 (0.45) ALDH1A1KDM4EHPGDHSD17B10RIPK1
Potassium Ion SCHEMBL6498890 0.81 RIPK1 (0.42) ALDH1A1RIPK1GAA
SCHEMBL14692601 0.79 SMN1; SMN2 (0.55) ALDH1A1KDM4EHPGDHSD17B10PDE4B
SCHEMBL6508436 0.78 ALDH1A1 (0.66) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL14691494 0.77 PDE4B (0.60) ALDH1A1PDE4BRIPK1NPSR1PDE4A
SCHEMBL14692586 0.76 HTT (0.64) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL29804250 0.76 HTT (0.64) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL6470606 0.75 ALDH1A1 (0.56) ALDH1A1KDM4EHPGDHSD17B10PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ALDH1A1 846/4885KDM4E 2424/4885HPGD 1845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.